Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Hikmat Abdel‐Razeq(University of Jordan), Banu Arun(The University of Texas MD Anderson Cancer Center)
Cited by 36
Related Papers
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
|International Journal of Oncology|2015|114